15.452 articles found

Dreaming furiously? A sleep laboratory study on the dream content of people with Parkinson's disease and with or without rapid eye movement sleep behavior disorder.

Valli K, Frauscher B, Peltomaa T, Gschliesser V, Revonsuo A, Högl B.

Sleep Med · 2015-01-16

DOI: 10.1016/j.sleep.2014.10.014PMID: 25683562

Low-frequency repetitive transcranial magnetic stimulation on Parkinson motor function: a meta-analysis of randomised controlled trials.

Zhu H, Lu Z, Jin Y, Duan X, Teng J, Duan D.

Acta Neuropsychiatr · 2015-01-16

DOI: 10.1017/neu.2014.43PMID: 25592544

Effects of dance on motor functions, cognitive functions, and mental symptoms of Parkinson's disease: a quasi-randomized pilot trial.

Hashimoto H, Takabatake S, Miyaguchi H, Nakanishi H, Naitou Y.

Complement Ther Med · 2015-01-16

DOI: 10.1016/j.ctim.2015.01.010PMID: 25847558

A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Cornejo-Olivas MR, Torres L, Mata IF, Mazzetti P, Rivas D, Cosentino C, Inca-Martinez M, Cuba JM, Zabetian CP, Leverenz JB.

Parkinsonism Relat Disord · 2015-01-15

DOI: 10.1016/j.parkreldis.2015.01.005PMID: 25817512

Paired neurophysiological and clinical study of the brainstem at different stages of Parkinson's Disease.

de Natale ER, Ginatempo F, Paulus KS, Manca A, Mercante B, Pes GM, Agnetti V, Tolu E, Deriu F.

Clin Neurophysiol · 2015-01-12

DOI: 10.1016/j.clinph.2014.12.017PMID: 25622530

Management of bipolar I depression: clinical utility of lurasidone.

Findlay LJ, El-Mallakh P, El-Mallakh RS.

Ther Clin Risk Manag · 2015-01-08

DOI: 10.2147/tcrm.s57695PMID: 25609973

Abnormalities of vestibular-evoked myogenic potentials in idiopathic Parkinson's disease are associated with clinical evidence of brainstem involvement.

de Natale ER, Ginatempo F, Paulus KS, Pes GM, Manca A, Tolu E, Agnetti V, Deriu F.

Neurol Sci · 2015-01-08

DOI: 10.1007/s10072-014-2054-4PMID: 25567081

Comparison of strength training, aerobic training, and additional physical therapy as supplementary treatments for Parkinson's disease: pilot study.

Carvalho A, Barbirato D, Araujo N, Martins JV, Cavalcanti JL, Santos TM, Coutinho ES, Laks J, Deslandes AC.

Clin Interv Aging · 2015-01-07

DOI: 10.2147/cia.s68779PMID: 25609935

Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study.

Abbruzzese G, Barone P, Ceravolo R, Fabbrini G, Lessi P, Ori A, Simoni L, Tinazzi M, Antonini A.

Neurol Sci · 2015-01-07

DOI: 10.1007/s10072-014-2060-6PMID: 25564417

A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease.

Morris ME, Menz HB, McGinley JL, Watts JJ, Huxham FE, Murphy AT, Danoudis ME, Iansek R.

Neurorehabil Neural Repair · 2015-01-07

DOI: 10.1177/1545968314565511PMID: 25567121

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.

Liu C, Cholerton B, Shi M, Ginghina C, Cain KC, Auinger P, Parkinson Study Group DATATOP Investigators, Zhang J.

Parkinsonism Relat Disord · 2015-01-05

DOI: 10.1016/j.parkreldis.2014.12.027PMID: 25596881

Functional and clinical relevance of oscillatory activity within cortico-basal-ganglia circuits in Parkinson's disease

Oswal A.

· 2015-01-01